research@carolinaclinicalresearch.com
(704) 290-4587

STUDY AREA:
PULMONARY

Carolina Clinical Research specializes in pulmonary (lung) disporders. With several trials available, we are on the front lines of developing new treatments for many pulmonary disorders, including COPD.   

We currently are conducting two clinical trials, RPL554-CO-302: A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients with COPD, and EFC16750: Study to Assess the Efficacy, Safety, and Tolerability of SAR440340?REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-1).

Eligible study participants can recieve study treatment and medications at no cost, and may be eligible for additional compensation, including study stipends, expense reimbursements, and free transportation.  

Click Here for trial information (RLP554-CO-302)

 Click here to request participant information

 

 Click Here for Trial Information (EFC16750) 

Click here to request participant information 

img